← Open Payments lookup

MICHAEL PEACOCK: Open Payments

NPI 1487636742 · EASTMAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,935 in 60 payments from 17 companies in 2025. Trend: 2023 $846 · 2024 $1,160 · 2025 $1,935

Food & beverage: $1,854Education: $81
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.19$692
Otsuka America Pharmaceutical, Inc.15$489
SK Life Science, Inc.2$157
Teva Pharmaceuticals USA, Inc.2$104
Otsuka Pharmaceutical Development & Commercialization, Inc.1$103
Lundbeck LLC5$93
UCB, Inc.3$70
Esperion Therapeutics, Inc.2$30
AstraZeneca Pharmaceuticals LP2$28
Bayer Healthcare Pharmaceuticals Inc.1$24

Products named: REXULTI, INGREZZA, Briviact, Nayzilam, NEXLETOL, Kerendia, Zunveyl, AUSTEDO XR.

Industry payments across GA — which companies pay providers there.